x
Filter:
Filters applied
- Coronavirus (COVID-19) Collection
- SeroprevalenceRemove Seroprevalence filter
- Enzyme-linked immunosorbent assayRemove Enzyme-linked immunosorbent assay filter
- 2020 - 2022Remove 2020 - 2022 filter
Coronavirus (COVID-19) Collection
1 Results
- Research ArticleOpen Access
Seroprevalence of infection-induced SARS-CoV-2 antibodies among health care users of Northern Italy: results from two serosurveys (October-November 2019 and September-October 2021)
International Journal of Infectious DiseasesVol. 124p49–54Published online: September 15, 2022- Costanza Vicentini
- Valerio Bordino
- Alessandro Roberto Cornio
- Davide Meddis
- Noemi Marengo
- Savina Ditommaso
- and others
Cited in Scopus: 1COVID-19, caused by SARS-CoV-2, was declared a public health emergency of international concern on January 30, 2020. As of June 12, 2022, there have been 533,160,628 confirmed cases worldwide, including over 6 million deaths (WHO, 2022).